ATE432708T1 - Therapeutische anwendungen von beta-casein a2 und nahrungsergänzung mit beta-casein a2 - Google Patents
Therapeutische anwendungen von beta-casein a2 und nahrungsergänzung mit beta-casein a2Info
- Publication number
- ATE432708T1 ATE432708T1 AT03770160T AT03770160T ATE432708T1 AT E432708 T1 ATE432708 T1 AT E432708T1 AT 03770160 T AT03770160 T AT 03770160T AT 03770160 T AT03770160 T AT 03770160T AT E432708 T1 ATE432708 T1 AT E432708T1
- Authority
- AT
- Austria
- Prior art keywords
- casein
- beta
- sup
- cholesterol
- density lipoprotein
- Prior art date
Links
- 102000011632 Caseins Human genes 0.000 title abstract 7
- 108010076119 Caseins Proteins 0.000 title abstract 7
- 235000021247 β-casein Nutrition 0.000 title abstract 7
- 235000015872 dietary supplement Nutrition 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 10
- 235000012000 cholesterol Nutrition 0.000 abstract 5
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract 4
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract 4
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract 2
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract 2
- 108010062497 VLDL Lipoproteins Proteins 0.000 abstract 2
- 101710095342 Apolipoprotein B Proteins 0.000 abstract 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ52195502 | 2002-10-04 | ||
PCT/NZ2003/000222 WO2004030690A1 (en) | 2002-10-04 | 2003-10-03 | THERAPEUTIC USES OF β-CASEIN A2 AND DIETARY SUPPLEMENT CONTAINING β-CASEIN A2 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE432708T1 true ATE432708T1 (de) | 2009-06-15 |
Family
ID=32065083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03770160T ATE432708T1 (de) | 2002-10-04 | 2003-10-03 | Therapeutische anwendungen von beta-casein a2 und nahrungsergänzung mit beta-casein a2 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060280802A1 (de) |
EP (1) | EP1562629B1 (de) |
JP (1) | JP4870355B2 (de) |
KR (1) | KR101065099B1 (de) |
CN (1) | CN100377740C (de) |
AT (1) | ATE432708T1 (de) |
AU (1) | AU2003278625A1 (de) |
CA (1) | CA2500530C (de) |
DE (1) | DE60327880D1 (de) |
DK (1) | DK1562629T3 (de) |
ES (1) | ES2329031T3 (de) |
HK (1) | HK1082910A1 (de) |
NZ (1) | NZ538904A (de) |
WO (1) | WO2004030690A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004004450A1 (en) * | 2002-07-03 | 2004-01-15 | A2 Corporation Limited | Method for altering fatty acid composition of milk |
CN101410131B (zh) * | 2006-06-09 | 2012-09-12 | 森永乳业株式会社 | 脂质代谢改善剂 |
ES2400631T3 (es) * | 2008-12-09 | 2013-04-11 | Unilever Nv | Dulces helados aireados y procedimientos de producción de los mismos |
SG10201709509RA (en) | 2013-05-31 | 2017-12-28 | A2 Milk Co Ltd | Beta-Casein A2 And Prevention Of Inflammation Of The Bowel |
JP6436592B2 (ja) * | 2013-07-12 | 2018-12-12 | ズィ・エイツー・ミルク・カンパニー・リミテッド | ベータカゼインa2およびラクトース不耐性の症状の低減または予防 |
WO2015026245A1 (en) * | 2013-08-23 | 2015-02-26 | The A2 Milk Company Limited | Beta-casein a2 and blood glucose levels |
CA2826315A1 (en) | 2013-09-06 | 2015-03-06 | Mattawa Industrial Services Inc. | Elevation conveyance system and method |
US10702580B2 (en) * | 2015-05-22 | 2020-07-07 | The A2 Milk Company Limited | Beta-casein A2 and antioxidant capacity |
CA3036494C (en) * | 2016-09-30 | 2022-10-18 | The A2 Milk Company Limited | Beta-caseins and gut microbiota |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06165655A (ja) * | 1992-06-26 | 1994-06-14 | Meiji Milk Prod Co Ltd | コレステロール低減用組成物 |
AU691362B2 (en) * | 1994-11-04 | 1998-05-14 | New Zealand Dairy Board | Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
US6570060B2 (en) * | 1995-05-16 | 2003-05-27 | Mclachlan Corran Norman Stuart | Milk lacking β-casein A1 |
AU723396B2 (en) * | 1995-05-16 | 2000-08-24 | Corran Norman Stuart Mclachlan | Food product and process |
AU771754B2 (en) * | 1999-06-29 | 2004-04-01 | New Zealand Milk Institute Limited, The | Prophylactic dietary supplement based on milk |
-
2003
- 2003-09-29 US US10/530,209 patent/US20060280802A1/en not_active Abandoned
- 2003-10-03 CN CNB2003801049265A patent/CN100377740C/zh not_active Expired - Lifetime
- 2003-10-03 DE DE60327880T patent/DE60327880D1/de not_active Expired - Lifetime
- 2003-10-03 NZ NZ538904A patent/NZ538904A/en not_active IP Right Cessation
- 2003-10-03 AU AU2003278625A patent/AU2003278625A1/en not_active Abandoned
- 2003-10-03 WO PCT/NZ2003/000222 patent/WO2004030690A1/en active Application Filing
- 2003-10-03 KR KR1020057005882A patent/KR101065099B1/ko active IP Right Grant
- 2003-10-03 ES ES03770160T patent/ES2329031T3/es not_active Expired - Lifetime
- 2003-10-03 DK DK03770160T patent/DK1562629T3/da active
- 2003-10-03 JP JP2004541349A patent/JP4870355B2/ja not_active Expired - Lifetime
- 2003-10-03 CA CA2500530A patent/CA2500530C/en not_active Expired - Lifetime
- 2003-10-03 AT AT03770160T patent/ATE432708T1/de not_active IP Right Cessation
- 2003-10-03 EP EP03770160A patent/EP1562629B1/de not_active Expired - Lifetime
-
2006
- 2006-03-02 HK HK06102730A patent/HK1082910A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2004030690A1 (en) | 2004-04-15 |
CN100377740C (zh) | 2008-04-02 |
CN1720062A (zh) | 2006-01-11 |
KR101065099B1 (ko) | 2011-09-16 |
EP1562629A4 (de) | 2007-08-29 |
ES2329031T3 (es) | 2009-11-20 |
HK1082910A1 (en) | 2006-06-23 |
JP2006501299A (ja) | 2006-01-12 |
CA2500530C (en) | 2013-01-08 |
AU2003278625A1 (en) | 2004-04-23 |
US20060280802A1 (en) | 2006-12-14 |
CA2500530A1 (en) | 2004-04-15 |
JP4870355B2 (ja) | 2012-02-08 |
EP1562629A1 (de) | 2005-08-17 |
NZ538904A (en) | 2009-04-30 |
DK1562629T3 (da) | 2009-10-12 |
KR20050087785A (ko) | 2005-08-31 |
DE60327880D1 (de) | 2009-07-16 |
EP1562629B1 (de) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1082910A1 (en) | Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2 | |
UA88633C2 (ru) | Структурированная композиция на основе липидов, способ ее изготовления и способ снижения атерогенного риска человека | |
Cordova et al. | The cardiovascular protective effect of red wine | |
NO990559D0 (no) | Stanolsammensetninger og anvendelse derav | |
CO5550402A2 (es) | Composicion para disminuir el colesterol en la sangre | |
MY121405A (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines | |
BR9707713A (pt) | Composição e sua utilização como umm suplemento alimentar ou para reduzir o nìvel plasmático de lipìdios. | |
WO2004016101A3 (en) | Compositions comprising dietary fat complexer and methods for their use | |
BR0209856A (pt) | Método para a destruição de oocistos | |
WO2001032160A3 (en) | Modification of cholesterol concentrations with citrus phytochemicals | |
AR025320A1 (es) | Composicion liquida para mejorar el pan | |
WO2004089992A8 (ja) | 改質アラビアガムおよびその用途 | |
Bellido et al. | The Mediterranean and CHO diets decrease VCAM-1 and E-selectin expression induced by modified low-density lipoprotein in HUVECs | |
Cater | Plant stanol ester: review of cholesterol‐lowering efficacy and implications for coronary heart disease risk reduction | |
IL160533A0 (en) | Methods of screening molecules that are used to prevent cardiovascular diseases | |
DK1660097T3 (da) | Fysiologisk aktiv sammensætning baseret på phosphatidylserin | |
DK1611794T3 (da) | Margarinelignende fødevaresammensætning med reduceret fedtindhold | |
ATE290795T1 (de) | Medizinische zusammensetzung zur behandlung und/oder zur verhinderung von unterernährung | |
BRPI0414628A (pt) | incorporação de fitoesteróis em aromatizantes | |
Meletis | Dietary and lifestyle interventions for a healthy heart | |
DE69908259D1 (de) | Neues anethanol enthaltend klares gegebenfalls alkoholisches getränk und trübes verdünntes getränk hergestellt durch verdünnung | |
Braith | Does resistance exercise training reduce the risk of cardiovascular disease? | |
Slaiby | Effect of chronic and non-chronic moderate wine consumption upon rat lipoprotein profile in the blood.(c2002) | |
WO1991015204A3 (en) | Method and agents for the selective reduction of lp(a) | |
Preboth | Cardiovascular benefits of soy protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |